Johnson & Johnson is to buy Los Angeles-based biotech firm Cougar Biotechnology for $970 million.The purchase, expected to go through …
Johnson & Johnson's monoclonal antibody Simponi has been given regulatory approval in Canada.Simponi (golimumab) has been given the green light …